prostate disease
Information
- Disease name
- prostate disease
- Disease ID
- DOID:47
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03543189 | Active, not recruiting | Phase 1/Phase 2 | Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy | October 3, 2018 | December 2024 |
| NCT05682742 | Active, not recruiting | N/A | Clinical Investigation of the da Vinci Surgical System | December 12, 2022 | August 31, 2028 |
| NCT00756561 | Completed | HOP-2A - Intratesticular Hormone Levels | September 2008 | December 2009 | |
| NCT05399940 | Completed | The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters | January 1, 2018 | May 20, 2022 | |
| NCT05803096 | Completed | Phase 4 | Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain | December 12, 2021 | September 9, 2022 |
| NCT01307852 | Completed | Phase 1 | In Vivo Dosimetry During Prostate Cancer Radiotherapy | November 2011 | September 2015 |
| NCT00037141 | Completed | Phase 1/Phase 2 | Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) | March 2002 | March 2004 |
| NCT05834270 | Completed | N/A | Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH | May 1, 2022 | December 1, 2022 |
| NCT03503643 | Enrolling by invitation | Hemi-Gland Cryoablation for Prostate Cancer at UCLA | September 14, 2017 | December 31, 2025 | |
| NCT05470127 | Not yet recruiting | N/A | Evaluation of a Soft Tissue Biopsy System for Trans-rectal and Trans-perineal Biopsy of the Prostate | August 1, 2022 | September 1, 2023 |
| NCT05902637 | Recruiting | N/A | The Efficacy Of Mapping For Cognitive Prostate Biopsy | March 1, 2023 | September 1, 2023 |
| NCT04288427 | Recruiting | N/A | 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy | September 25, 2020 | November 30, 2025 |
| NCT04599218 | Recruiting | N/A | MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer | August 21, 2020 | January 15, 2026 |
| NCT04656678 | Recruiting | N/A | Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer | November 25, 2020 | October 30, 2025 |
| NCT04026763 | Unknown status | N/A | MR/TRUS Fusion Guided Prostate Biopsy | May 11, 2018 | December 2021 |
| NCT03589196 | Unknown status | N/A | Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT | March 10, 2018 | December 1, 2019 |
| NCT04699552 | Withdrawn | N/A | Effect of Laser Settings on Postoperative Voiding Symptoms in Patients Undergoing Holmium Laser Enucleation of the Prostate | December 2020 | December 2021 |
| NCT03658408 | Withdrawn | Phase 2 | 4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy | October 3, 2018 | October 30, 2018 |
| NCT03597386 | Withdrawn | ConfirmMDx Assay in Multiparametric MRI (mpMRI) PIRADS Scored Lesions After a Negative MR/US Fusion Biopsy | January 23, 2019 | January 24, 2019 |
- Disase is a (Disease Ontology)
- DOID:48
- Cross Reference ID (Disease Ontology)
- ICD10CM:N42.9
- Cross Reference ID (Disease Ontology)
- ICD9CM:602.9
- Cross Reference ID (Disease Ontology)
- MESH:D011469
- Cross Reference ID (Disease Ontology)
- NCI:C26865
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:30281009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0033575